Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incomplete Family History and Meeting Algorithmic Criteria for Genetic Evaluation of Hereditary Cancer.

JAMA network open - 1 Oct 2025

Harris Adrian, Bather Jemar R, Bradshaw Richard L, Kawamoto Kensaku, Del Fiol Guilherme, Kohlmann Wendy K, Chavez-Yenter Daniel, Monahan Rachel, Chambers Rachelle L, Sigireddi Meenakshi, Goodman Melody S, Kaphingst Kimberly A

Abstract excerpt

Importance: Incomplete electronic health record (EHR) documentation may limit the effectiveness of clinical decision support (CDS) algorithms designed to identify patients eligible for hereditary cancer genetic evaluation. Objectives: To determine whether a CDS algorithm can identify patients who meet criteria for hereditary cancer genetic evaluation when family history data are incompletely documented in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decision Support Systems, Clinical

Share to Electronic Health Records

Share to Genetic Testing

Share to Medical History Taking

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 41148137
DOI: 10.1001/jamanetworkopen.2025.39870
PMCID: PMC12569706

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incomplete Family History and Meeting Algorithmic Criteria for Genetic Evaluation of Hereditary Cancer.PMID 41148137Read ↗

Streamlining Inherited Cancer Identification via an EMR-Integrated Risk Assessment Platform: A Nonrandomized Clinical Trial.Semantic proximity Read ↗

Identification of Individuals With Hereditary Cancer Risk Through Multiple Data Sources: A Population-Based Method Using the GARDE Platform and The Utah Population Database.Semantic proximity Read ↗

Screening Familial Risk for Hereditary Breast and Ovarian Cancer.Semantic proximity Read ↗

Population-Level Identification of Patients With Lynch Syndrome for Clinical Care, Quality Improvement, and Research.Semantic proximity Read ↗

Quality of Clinician-Reported Cancer History When Ordering Genetic TestingSemantic proximity Read ↗

Disease and Participant-Related Correlates of Genetic Testing Completion for Hereditary Eye Disorders in a Cohort of Over 1800 PatientsSemantic proximity Read ↗

Current management of hereditary cancer syndromes in ovarian and endometrial cancer: a Japanese study.Semantic proximity Read ↗

Stagnation in quality of next-generation sequencing assays for the diagnosis of hereditary hematopoietic malignanciesSemantic proximity Read ↗

Validation of a Digital Identification Tool for Individuals at Risk for Hereditary Cancer SyndromesSemantic proximity Read ↗

Family history and cancer risk study (FOREST): A clinical trial assessing electronic patient-directed family history input for identifying patients at risk of hereditary cancer.Semantic proximity Read ↗

Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery systemSemantic proximity Read ↗

Patient uptake of updated genetic testing following uninformative BRCA1 and BRCA2 results.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.